Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
san diego blog main
18
×
san diego top stories
18
×
vc
18
×
life sciences
biotech
national top stories
san francisco blog main
boston blog main
startups
venture capital
new york blog main
san francisco top stories
boston top stories
new york top stories
deals
texas blog main
wisconsin blog main
wisconsin top stories
detroit blog main
detroit top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego
seattle blog main
seattle top stories
texas top stories
boulder/denver blog main
boulder/denver top stories
fda
indiana blog main
indiana top stories
ipo
biogen
cancer
financing
funding
gene therapy
celgene
What
roundup
bio
san
healthcare
new
diego
ipo
advance
devices
drugs
health
life
medicines
therapy
awards
billions
biogen
biology
companies
company
cytokine
deal
diego’s
diseases
dollars
drug
economic
enhanced
gene
hundreds
impact
investors
latest
makes
medical
medicine
million
moves
patients
public
Language
unset
Current search:
vc
×
" san diego blog main "
×
" san diego top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
4 years ago
Review: Inside the House of Lies at Theranos
@xconomy.com
5 years ago
San Diego Life Sciences Roundup: MedCrypt, LunaDNA, Dynacure & More
@xconomy.com
5 years ago
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More
@xconomy.com
5 years ago
Meet the Xconomy Awards San Diego Digital Trailblazer Finalists
@xconomy.com
5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com
5 years ago
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
@xconomy.com
5 years ago
ResMed Boosts Connected Health Play With $225M Propeller Health Deal
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Nominations Open for San Diego’s Inaugural Xconomy Awards
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?
@xconomy.com
5 years ago
Virtual Physical Therapy Firms Reflexion and MindMaze Probe Markets
@xconomy.com
6 years ago
Synthorx Raises $63M to Advance Suite of Enhanced Cytokine Drugs